Philip Morris International raises quarterly dividend by 8.9%

Philip Morris International (PM) approved an 8.9% increase in its quarterly dividend to $1.47 per share, extending its 18-year streak of dividend payments and highlighting consistent shareholder returns. This positive development follows mixed Q2 2025 results, where adjusted EPS of $1.91 surpassed expectations, but revenue of $10.14 billion missed forecasts. Reflecting potential headwinds, UBS subsequently lowered its price target for PM to $166 from $177, maintaining a Neutral rating, primarily due to reduced growth projections for the company's key ZYN nicotine pouch segment, despite smoke-free products contributing 41% of H1 2025 net revenues.

Analysis

Philip Morris International (PM) presents a conflicting picture for investors, balancing strong shareholder returns against emerging operational headwinds. The company demonstrated confidence in its cash flow by approving an 8.9% increase in its quarterly dividend to $1.47 per share, extending a consistent 18-year history of payments and marking a 7.1% compound annual growth rate since 2008. This positive signal for income investors, however, is juxtaposed with mixed second-quarter 2025 results. While adjusted EPS of $1.91 surpassed the $1.86 forecast, revenue of $10.14 billion missed expectations of $10.31 billion. This revenue shortfall appears to be a key factor in UBS's decision to lower its price target to $166 from $177, citing reduced forecasts for the pivotal ZYN nicotine pouch brand. Specifically, UBS cut its FY2025/2026 US ZYN can estimates, impacting revenue projections for a product central to PM's growth narrative. Although the smoke-free segment now accounts for a substantial 41% of total net revenues, the downward revision for ZYN suggests potential deceleration in this critical transition, creating uncertainty around the company's near-term growth trajectory.

Key Decisions for Investors

• Income-focused investors may find the 8.9% dividend hike and the resulting 3.34% yield attractive, as it signals strong management confidence in future cash flows despite recent operational challenges.
• Investors should closely monitor the performance of the ZYN brand, as the downward revision in UBS's growth forecasts highlights a significant risk to the company's smoke-free transition and overall growth narrative.
• Given the divergence between the EPS beat and the revenue miss, it is prudent to weigh the security of the dividend against the potential for slowing growth in the smoke-free segment before initiating or adding to a position.